NU6300
NU6300 is a covalent, irreversible and ATP-competitive CDK2 inhibitor with an IC50 value of 0.16 μM. NU6300 can be used for the research of eukaryotic cell cycle- and transcription-related[1].
Product Specifications
CAS Number
2070015-09-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NU6300.html
Purity
98.44
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(C(C=C1)=CC=C1NC2=NC(OCC3CCCCC3)=C4C(NC=N4)=N2)(C=C)=O
Molecular Formula
C20H23N5O3S
Molecular Weight
413.49
Precautions
H302, H315, H319, H335
References & Citations
[1]Anscombe E, et al. Identification and Characterization of an Irreversible Inhibitor of CDK2. Chem Biol. 2015 Sep 17;22 (9) :1159-1164.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Respiratory Syncytial Virus Fusion Protein Antibody (RSV-F) Antibody
![Rabbit Polyclonal NDUFB8 Antibody [mFluor Violet 450 SE]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Rabbit Polyclonal NDUFB8 Antibody [mFluor Violet 450 SE]
SLC6A18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Multiplex Assay Kit for Acetylcholine (ACH), etc. by FLIA (Flow Luminescence Immunoassay)